Genomic Testing: What Makes Your Tumor Grow? - Metastatic Breast Cancer Trial Talk

Inside Clinical Trials

The U.S. Food and Drug Administration (FDA) has approved two tests to identify genetic alterations in tumors. These tests, which are done on a tumor sample, look for hundreds of known genetic mutations and alterations linked to cancer. The results can potentially be used to make treatment decisions.

Genomic tumor testing is currently not the standard of care for breast cancer patients–but one day it might be. Below you can read about the two tests.

Last Modified on March 4, 2021



for past articles or specific information.